1. Home
  2. RNTX vs AEC Comparison

RNTX vs AEC Comparison

Compare RNTX & AEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rein Therapeutics Inc.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

89.0M

Sector

Health Care

ML Signal

HOLD

Logo Anfield Energy Inc.

AEC

Anfield Energy Inc.

HOLD

Current Price

$4.49

Market Cap

73.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNTX
AEC
Founded
2001
1989
Country
United States
Canada
Employees
10
15
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
89.0M
73.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNTX
AEC
Price
$0.93
$4.49
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
579.2K
54.3K
Earning Date
05-15-2026
05-01-2015
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$3.66
52 Week High
$2.18
$12.49

Technical Indicators

Market Signals
Indicator
RNTX
AEC
Relative Strength Index (RSI) 43.90 52.31
Support Level $0.85 $4.17
Resistance Level $1.05 $5.20
Average True Range (ATR) 0.07 0.33
MACD -0.00 0.04
Stochastic Oscillator 33.74 44.59

Price Performance

Historical Comparison
RNTX
AEC

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About AEC Anfield Energy Inc.

Anfield Energy Inc is a mineral exploration and development company. This company focuses on uranium and vanadium development and near-term production. The exploration project of the company includes Shootaring Canyon Mill and Velvet-Wood and Slick Rock Uranium Project from Uranium One and The West Slope Project located in Montrose and San Miguel Counties in southwestern Colorado. The company's geographical segments are Canada and the United States.

Share on Social Networks: